Skip to main content
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
1. A. P. Abernethy et al., “Rapid-Learning system for cancer care,” J. Clin. Oncol. 28(27), 42684274 (2010).
2. P. Lambin et al., “The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer,” Radiother. Oncol. 96(2), 145152 (2010).
3. R. J. Gillies, D. Verduzco, and R. A. Gatenby, “Evolutionary dynamics of carcinogenesis and why targeted therapy does not work,” Nat. Rev. Cancer 12(7), 487493 (2012).
4. R. Sullivan et al., “Delivering affordable cancer care in high-income countries,” Lancet Oncol. 12(10), 933980 (2011).
5. C. Oberije et al., “A prospective study to compare doctor versus model predictions for outcome in lung cancer patients: Pick the winner,” Radiother. Oncol. 106(Suppl. 2), S53 (2013).
6. P. Lambin et al., “‘Rapid learning health care in oncology’—An approach towards decision support systems enabling customised radiotherapy,” Radiother. Oncol. (in press).
7. P. Lambin et al., “Predicting outcomes in radiation oncology–multifactorial decision support systems,” Nat. Rev. Clin. Oncol. 10(1), 2740 (2013).
8. J. D. Cox, “Clinical science and patient care: Lessons from cooperative randomized clinical trials,” Int. J. Radiat. Oncol., Biol., Phys. 39(2), 273274 (1997).
9. D. L. Sackett, W. M. Rosenberg, J. A. Gray, R. B. Haynes, and W. S. Richardson, “Evidence based medicine: What it is and what it isn't,” Br. Med. J. 312(7023), 7172. (1996).
10. C. M. Nutting, J. P. Morden, K. J. Harrington, T. G. Urbano, S. A. Bhide, C. Clark, E. A. Miles, A. B. Miah, K. Newbold, M. Tanay, F. Adab, S. J. Jefferies, C. Scrase, B. K. Yap, R. P. A’Hern, M. A. Sydenham, M. Emson, and E. Hall, “Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial,” Lancet Oncol. 12(2), 127136 (2011).
11. S. L. Gulliford, A. B. Miah, S. Brennan, D. McQuaid, C. H. Clark, M. Partridge, K. J. Harrington, J. P. Morden, E. Hall, and C. M. Nutting, “Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial,” Radiother. Oncol. 104(2), 205212 (2012).
12. H. James, A. Beavis, G. Budgell, C. Clark, D. Convery, J. Mott, D. Dearnaley, R. Perry, and C. Scrase, “Guidance for the clinical implementation of intensity modulated radiation therapy,” IPEM Report 96 (Institute of Physics and Engineering in Medicine, York, 2008).
13. J. van Loon, J. Grutters, and F. Macbeth, “Evaluation of novel radiotherapy technologies: What evidence is needed to assess their clinical and cost effectiveness, and how should we get it?,” Lancet Oncol. 13(4), e169e177 (2012).
14. L. J. Peters et al., “Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02,” J. Clin. Oncol. 28(18), 29963001 (2010).
15. C. X. Yu and G. Tang, “Intensity-modulated arc therapy: Principles, technologies and clinical implementation,” Phys. Med. Biol. 56, R31R54 (2011).

Data & Media loading...


Article metrics loading...



There is no abstract available for this article.


Full text loading...


Access Key

  • FFree Content
  • OAOpen Access Content
  • SSubscribed Content
  • TFree Trial Content
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd